Skip to main content

Yaman Tarabishy, MD

Board Certifications

Anatomic and Clinical Pathology


Gastrointestinal Pathology, Hepatic Pathology




  • Residency – Anatomic and Clinical Pathology, Washington University, St. Louis, Missouri
  • Medical School – University of Damascus School of Medicine, Syria
  • Dr. Tarabishy has published 17 peer-reviewed articles and abstracts.
  • Joined ProPath in 2018

Peer-Reviewed Articles

  1. Dhingra S, Mahadik JD, Tarabishy Y, May SB, Vierling JM. Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis. Pathology. 2022 May 5:S0031-3025(22)00123-4. doi: 10.1016/j.pathol.2022.01.009. [Epub ahead of print]

  2. Yang C, Tarabishy Y, Dassopoulos T, Nalbantoglu Ilk. Clinical, histologic, and immunophenotypic features of serrated polyps in patients with inflammatory bowel disease. Gastroenterol Res. 2018;11(5):355-360.

  3. Salimian KJ, Waters KM, Eze O, Pezhouh MK, Tarabishy Y, Shin EJ, Canto MI, Voltaggio L, Montgomery EA. Definition of Barrett Esophagus in the United States: support for retention of a requirement for goblet cells. Am J Surg Pathol. 2018;42(2):264-268.

  4. Tarabishy Y, Pittman ME. Soft tissue tumors with myxoid stroma: a review of distinguishing clinical and pathological features. AJSP Rev Reports. 2017;22(2):94-101.

  5. Tarabishy Y, Montgomery EA. Vascular tumors of intermediate malignancy and angiosarcoma: a review. AJSP Rev Reports. 2017;22(2):108-115.

  6. Messmer M, Upreti S, Tarabishy Y, Mazumder N, Chowdhury R, Yarchoan M, Holdhoff M. Ipilimumab-induced enteritis without colitis: a new challenge. Case Rep Oncol. 2016;9(3):705-173.

  7. Visscher DW, Frost MH, Hartmann LC, Hartmann LC, Frank RD, Vierkant RA, McCullough AE, Winham SJ, Vachon CM, Ghosh K, Brandt KR, Farrell AM, Tarabishy Y, Hieken TJ, Haddad TC, Kraft RA, Radisky DC, Degnim AC. Clinicopathologic features of breast cancers that develop in women with previous benign breast disease. Cancer. 2016;122(3):378-385.

  8. Banan B, Chung H, Xiao Z, Tarabishy Y, Jia J, Manning P, Upadhya GA, Mohanakumar T, Lin Y, Chapman WC. Normothermic extracorporeal liver perfusion for donation after cardiac death (DCD) livers. Surg (United States). 2015;158(6):1642-1650.

  9. Lewis JS, Tarabishy Y, Luo J, Mani H, Bishop JA, Leon ME, Prasad ML, Xu H, Di Palma S. Inter- and intra-observer variability in the classification of extracapsular extension in p16 positive oropharyngeal squamous cell carcinoma nodal metastases. Oral Oncol. 2015;51(11):985-990.

  10. Chien J, Sicotte H, Fan JB, Humphray S, Cunningham JM, Kalli KR, Oberg AL, Hart SN, Li Y, Davila JI, Baheti S, Wang C, Dietmann S, Atkinson EJ, Asmann YW, Bell DA, Ota T, Tarabishy Y, Kuang R, Bibikova M, Cheetham RK, Grocock RJ, Swisher EM, Peden J, Bentley D, Kocher JP, Kaufmann SH, Hartmann LC, Shridhar V, Goode EL. TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer. Nucleic Acids Res. 2015;43(14):6945-6958.

  11. Pankratz VS, Degnim AC, Frank RD, Frost MH, Visscher DW, Vierkant RA, Hieken TJ, Ghosh K, Tarabishy Y, Vachon CM, Radisky DC, Hartmann LC. Model for individualized prediction of breast cancer risk after a benign breast biopsy. J Clin Oncol. 2015;33(8):923-929.

  12. Wahner Hendrickson AE, Hawthorne KM, Goode EL, Kalli KR, Goergen KM, Bakkum-Gamez JN, Cliby WA, Keeney GL, Visscher DW, Tarabishy Y, Oberg AL, Hartmann LC, Maurer MJ. Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic. Gynecol Oncol. 2015;137(1):77-85.

  13. Visscher DW, Nassar A, Degnim AC, Frost MH, Vierkant RA, Frank RD, Tarabishy Y, Radisky DC, Hartmann LC. Sclerosing adenosis and risk of breast cancer. Breast Cancer Res Treat. 2014;144(1):205-212.

  14. Hartmann LC, Radisky DC, Frost MH, Santen RJ, Vierkant RA, Benetti LL, Tarabishy Y, Ghosh K, Visscher DW, Degnim AC. Understanding the premalignant potential of atypical hyperplasia through its natural history: A longitudinal cohort study. Cancer Prev Res. 2014;7(2):211-217.


  1. Tarabishy Y, Karnes H, Koopmeiners A, Dehner L. Concordance between pre- and post-mortem diagnoses in pediatric autopsies. USCAP Meeting, Seattle, WA, 2016.

  2. Tarabishy Y, Nalbantoglu I. Clinical, histologic, and immunophenotypic features of serrated polyps in patients with inflammatory bowel disease.USCAP Meeting, Boston, MA, 2015.

  3. Tarabishy Y, Luo J, Mani H, Bishop J, Leon M, Prasad M, Xu H, Di Palma S, Lewis JS Jr.Interobserver variability in the classification of extracapsular extension in metastatic p16+ oropharyngeal squamous cell carcinoma.CAP ’14 – The Pathologists’ Meeting, Chicago, IL, 2014.

  4. Tarabishy Y, Hartmann LC, Frost MH, Maloney SD, Vierkant RA, Pankratz VS.Performance of the Gail model in individual women with benign breast disease. American Society of Clinical Oncology Annual Meeting, Chicago, IL, 2011.